Renal Cell Carcinoma is on the top 10 of the most incident cancers worldwide, being a third of patients diagnosed with advanced disease, for which no curative therapies are currently available. This article reports the antineoplastic effect of newly synthesized 3- nitroflavanones. Immunostaining was evaluated quantitatively, considering the percentage of positivity and intensity of staining.
For the full article – https://pubmed.ncbi.nlm.nih.gov/34139552/